83 FR 42301 - Proposed Data Collection Submitted for Public Comment and Recommendations
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 83, Issue 162 (August 21, 2018)
Centers for Disease Control and Prevention
Federal Register Volume 83, Issue 162 (August 21, 2018)
| Page Range | 42301-42303 | |
| FR Document | 2018-17980 |
[Federal Register Volume 83, Number 162 (Tuesday, August 21, 2018)] [Notices] [Pages 42301-42303] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-17980] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60-Day-18-1100; Docket No. CDC-2018-0070] Proposed Data Collection Submitted for Public Comment and Recommendations AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. ----------------------------------------------------------------------- SUMMARY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Identification of Behavioral and Clinical Predictors of Early HIV Infection (Project DETECT), which collects information from people testing for HIV in order to compare the performance characteristics of new point of care HIV tests for detection of early HIV infection and to identify behavioral and clinical predictors of early HIV infection. DATES: CDC must receive written comments on or before October 22, 2018. ADDRESSES: You may submit comments, identified by Docket No. CDC-2018- 0070 by any of the following methods:Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffery M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected]. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. 5. Assess information collection costs. Proposed Project Identification of Behavioral and Clinical Predictors of Early HIV Infection (Project DETECT)--(OMB No. 0920-1100 Exp: 2/29/2019)-- Extension--National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). [[Page 42302]] Background and Brief Description CDC provides guidelines for HIV testing and diagnosis for the United States, as well as technical guidance for its grantees. The purpose of this project is to assess characteristics of HIV testing technologies to update these guidance documents to reflect the latest available testing technologies, their performance characteristics, and considerations regarding their use. Specifically, CDC will describe behavioral and clinical characteristics of persons with early infection to help HIV test providers (including CDC grantees) choose which HIV tests to use, and target tests appropriately to persons at different levels of risk. This information will be disseminated primarily through guidance documents and articles in peer-reviewed journals. The primary study population will be persons at high risk for or diagnosed with HIV infection, many of whom will be men who have sex with men (MSM) because the majority of new HIV infections occur each year among this population. The goals of the project are to: (1) Characterize the performance of new HIV tests for detecting established and early HIV infection at the point of care, relative to each other and to currently used gold standard, non-POC tests, and (2) identify behavioral and clinical predictors of early HIV infection. Project DETECT will enroll 1,667 persons annually at the primary study site clinic in Seattle, and an additional 200 persons will be enrolled from other clinics in the greater Seattle area. The study will be conducted in two phases. Phase 1: After a clinic client consents to participate, he/she will be assigned a unique participant ID and will then undergo testing with the seven new HIV tests under study. While awaiting test results, participants will undergo additional specimen collections and complete the Phase 1 Enrollment Survey. Phase 2: All Phase 1 participants whose results on the seven tests under investigation are not in agreement with one another (``discordant'') will be considered to have a potential early HIV infection. Nucleic amplification testing that detects viral nucleic acids will be conducted to confirm an HIV diagnosis and rule out false positives. Study investigators expect that each year, 50 participants with discordant test results will be invited to participate in serial follow-up specimen collections to assess the time point at which all HIV test results resolve and become concordant positive (indicating enrollment during early infection) or concordant negative (indicating one or more false-positive test results in Phase 1). The follow-up schedule will consist of up to nine visits scheduled at regular intervals over a 70-day period. At each follow-up visit, participants will be tested with the new HIV tests and additional oral fluid and blood specimens will also be collected for storage and use in future HIV test evaluations at CDC. Participants will be followed up only to the point at which all their test results become concordant. At each time point, participants will be asked to complete the Phase 2 HIV Symptom and Care survey that collects information on symptoms associated with early HIV infection as well as access to HIV care and treatment since the last Phase 2 visit. When all tests become concordant (i.e., at the last Phase 2 visit) participants will complete the Phase 2 behavioral survey to identify any behavioral changes during follow-up. Of the 50 Phase 2 participants; it is estimated that no more than 26, annually, will have early HIV infection. All data for the proposed information collection will be collected via an electronic Computer Assisted Self- Interview (CASI) survey. Participants will complete the surveys on an encrypted computer, with the exception of the Phase 2 Symptom and Care survey, which will be administered by a research assistant and then electronically entered into the CASI system. Data to be collected via CASI include questions on sociodemographic characteristics, medical care, HIV testing, pre- exposure prophylaxis, antiretroviral treatment, sexually transmitted diseases (STD) history, symptoms of early HIV infection, substance use and sexual behavior. Data from the surveys will be merged with HIV test results and relevant clinical data using the unique identification (ID) number. Data will be stored on a secure server managed by the University of Washington Department of Medicine Information Technology (IT) Services. The participation of respondents is voluntary. There is no cost to the respondents other than their time. The total estimated annual burden hours for the proposed project are 2,110 hours. Estimated Annualized Burden Hours -------------------------------------------------------------------------------------------------------------------------------------------------------- Average Number of Number of burden per Total burden Type of respondents Form name respondents responses per response (in (in hours) respondent hours) -------------------------------------------------------------------------------------------------------------------------------------------------------- Persons eligible for study..................... Phase 1 Consent........................ 2,334 1 15/60 584 Enrolled participants.......................... Phase 1 Enrollment Survey A............ 1,667 1 45/60 1,250 Phase 1 Enrollment Survey B............ 200 1 60/60 200 Phase 2 Consent........................ 50 1 15/60 13 Phase 2 HIV Symptom and Care survey.... 50 9 5/60 38 Phase 2 Behavioral Survey.............. 50 1 30/60 25 --------------------------------------------------------------- Total...................................... ....................................... .............. .............. .............. 2,110 -------------------------------------------------------------------------------------------------------------------------------------------------------- Jeffrey M. Zirger, Acting Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2018-17980 Filed 8-20-18; 8:45 am] BILLING CODE 4163-18-P
![Federal Register / Vol. 83, No. 162 / Tuesday, August 21, 2018 / Notices 42301
traffic, the requested burden is communicable disease a year, with an respondents other than the time
approximately 23 hours. This total is average burden of seven minutes per required to make the report of illness or
estimated from 200 respondents report. This totals 23 burden hours death.
submitting domestic reports of death or annually. There is no burden to
ESTIMATED ANNUALIZED BURDEN HOURS
Number of Average
Type of Number of responses burden per Total burden
Form name
respondent respondents per response (in hours)
respondent (in hours)
Pilot in com- 42 CFR 70.11 Report of death or illness onboard aircraft 190 1 7/60 22
mand. operated by airline.
Master of ves- 42 CFR 70.4 Report by the master of a vessel or person 10 1 7/60 1
sel or per- in charge of conveyance of the incidence of a commu-
son in nicable disease occurring while in interstate travel.
charge of
conveyance.
Total ....... .............................................................................................. ........................ ........................ ........................ 23
Jeffrey M. Zirger, behavioral and clinical predictors of proposed collection, each proposed
Acting Chief, Information Collection Review early HIV infection. extension of existing collection of
Office, Office of Scientific Integrity, Office DATES: CDC must receive written information, and each reinstatement of
of the Associate Director for Science, Office comments on or before October 22, previously approved information
of the Director, Centers for Disease Control collection before submitting the
and Prevention.
2018.
collection to the OMB for approval. To
[FR Doc. 2018–17979 Filed 8–20–18; 8:45 am] ADDRESSES: You may submit comments, comply with this requirement, we are
BILLING CODE 4163–18–P identified by Docket No. CDC–2018– publishing this notice of a proposed
0070 by any of the following methods: data collection as described below.
• Federal eRulemaking Portal:
DEPARTMENT OF HEALTH AND Regulations.gov. Follow the instructions The OMB is particularly interested in
HUMAN SERVICES for submitting comments. comments that will help:
• Mail: Jeffrey M. Zirger, Information 1. Evaluate whether the proposed
Centers for Disease Control and Collection Review Office, Centers for collection of information is necessary
Prevention Disease Control and Prevention, 1600 for the proper performance of the
Clifton Road NE, MS–D74, Atlanta, functions of the agency, including
[60-Day–18–1100; Docket No. CDC–2018– Georgia 30329. whether the information will have
0070] Instructions: All submissions received practical utility;
must include the agency name and 2. Evaluate the accuracy of the
Proposed Data Collection Submitted Docket Number. CDC will post, without agency’s estimate of the burden of the
for Public Comment and change, all relevant comments to proposed collection of information,
Recommendations Regulations.gov. including the validity of the
Please note: Submit all comments methodology and assumptions used;
AGENCY: Centers for Disease Control and
through the Federal eRulemaking portal
Prevention (CDC), Department of Health 3. Enhance the quality, utility, and
(regulations.gov) or by U.S. mail to the
and Human Services (HHS). clarity of the information to be
address listed above.
ACTION: Notice with comment period. collected; and
FOR FURTHER INFORMATION: To request
more information on the proposed 4. Minimize the burden of the
SUMMARY: The Centers for Disease
project or to obtain a copy of the collection of information on those who
Control and Prevention (CDC), as part of
information collection plan and are to respond, including through the
its continuing effort to reduce public
instruments, contact Jeffery M. Zirger, use of appropriate automated,
burden and maximize the utility of
Information Collection Review Office, electronic, mechanical, or other
government information, invites the
Centers for Disease Control and technological collection techniques or
general public and other Federal
Prevention, 1600 Clifton Road NE, MS– other forms of information technology,
agencies the opportunity to comment on
D74, Atlanta, Georgia 30329; phone: e.g., permitting electronic submissions
a proposed and/or continuing
404–639–7570; Email: omb@cdc.gov. of responses.
information collection, as required by
the Paperwork Reduction Act of 1995. SUPPLEMENTARY INFORMATION: Under the 5. Assess information collection costs.
This notice invites comment on a Paperwork Reduction Act of 1995 (PRA) Proposed Project
proposed information collection project (44 U.S.C. 3501–3520), Federal agencies
titled Identification of Behavioral and must obtain approval from the Office of Identification of Behavioral and
sradovich on DSK3GMQ082PROD with NOTICES
Clinical Predictors of Early HIV Management and Budget (OMB) for each Clinical Predictors of Early HIV
Infection (Project DETECT), which collection of information they conduct Infection (Project DETECT)—(OMB No.
collects information from people testing or sponsor. In addition, the PRA also 0920–1100 Exp: 2/29/2019)—
for HIV in order to compare the requires Federal agencies to provide a Extension—National Center for HIV/
performance characteristics of new 60-day notice in the Federal Register AIDS, Viral Hepatitis, STD, and TB
point of care HIV tests for detection of concerning each proposed collection of Prevention (NCHHSTP), Centers for
early HIV infection and to identify information, including each new Disease Control and Prevention (CDC).
VerDate Sep<11>2014 17:31 Aug 20, 2018 Jkt 244001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\21AUN1.SGM 21AUN1](https://thefederalregister.org/doc/83_FR_42463/page/1.svg)
![42302 Federal Register / Vol. 83, No. 162 / Tuesday, August 21, 2018 / Notices
Background and Brief Description Phase 1: After a clinic client consents with early HIV infection as well as
to participate, he/she will be assigned a access to HIV care and treatment since
CDC provides guidelines for HIV
unique participant ID and will then the last Phase 2 visit. When all tests
testing and diagnosis for the United
undergo testing with the seven new HIV become concordant (i.e., at the last
States, as well as technical guidance for
tests under study. While awaiting test Phase 2 visit) participants will complete
its grantees. The purpose of this project
results, participants will undergo the Phase 2 behavioral survey to
is to assess characteristics of HIV testing additional specimen collections and identify any behavioral changes during
technologies to update these guidance complete the Phase 1 Enrollment follow-up. Of the 50 Phase 2
documents to reflect the latest available Survey. participants; it is estimated that no more
testing technologies, their performance Phase 2: All Phase 1 participants than 26, annually, will have early HIV
characteristics, and considerations whose results on the seven tests under infection.
regarding their use. Specifically, CDC investigation are not in agreement with
will describe behavioral and clinical All data for the proposed information
one another (‘‘discordant’’) will be collection will be collected via an
characteristics of persons with early considered to have a potential early HIV
infection to help HIV test providers electronic Computer Assisted Self-
infection. Nucleic amplification testing Interview (CASI) survey. Participants
(including CDC grantees) choose which that detects viral nucleic acids will be
HIV tests to use, and target tests will complete the surveys on an
conducted to confirm an HIV diagnosis encrypted computer, with the exception
appropriately to persons at different and rule out false positives. Study
levels of risk. This information will be of the Phase 2 Symptom and Care
investigators expect that each year, 50 survey, which will be administered by
disseminated primarily through participants with discordant test results
guidance documents and articles in a research assistant and then
will be invited to participate in serial electronically entered into the CASI
peer-reviewed journals. follow-up specimen collections to assess
The primary study population will be system. Data to be collected via CASI
the time point at which all HIV test include questions on sociodemographic
persons at high risk for or diagnosed results resolve and become concordant
with HIV infection, many of whom will characteristics, medical care, HIV
positive (indicating enrollment during
be men who have sex with men (MSM) testing, pre-exposure prophylaxis,
early infection) or concordant negative
because the majority of new HIV antiretroviral treatment, sexually
(indicating one or more false-positive
infections occur each year among this transmitted diseases (STD) history,
test results in Phase 1).
population. The goals of the project are symptoms of early HIV infection,
The follow-up schedule will consist
to: (1) Characterize the performance of substance use and sexual behavior.
of up to nine visits scheduled at regular
new HIV tests for detecting established intervals over a 70-day period. At each Data from the surveys will be merged
and early HIV infection at the point of follow-up visit, participants will be with HIV test results and relevant
care, relative to each other and to tested with the new HIV tests and clinical data using the unique
currently used gold standard, non-POC additional oral fluid and blood identification (ID) number. Data will be
tests, and (2) identify behavioral and specimens will also be collected for stored on a secure server managed by
clinical predictors of early HIV storage and use in future HIV test the University of Washington
infection. evaluations at CDC. Participants will be Department of Medicine Information
Project DETECT will enroll 1,667 followed up only to the point at which Technology (IT) Services.
persons annually at the primary study all their test results become concordant. The participation of respondents is
site clinic in Seattle, and an additional At each time point, participants will be voluntary. There is no cost to the
200 persons will be enrolled from other asked to complete the Phase 2 HIV respondents other than their time. The
clinics in the greater Seattle area. The Symptom and Care survey that collects total estimated annual burden hours for
study will be conducted in two phases. information on symptoms associated the proposed project are 2,110 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per Total burden
Type of respondents Form name responses per
respondents response (in hours)
respondent (in hours)
Persons eligible for study .................. Phase 1 Consent ............................. 2,334 1 15/60 584
Enrolled participants .......................... Phase 1 Enrollment Survey A ......... 1,667 1 45/60 1,250
Phase 1 Enrollment Survey B ......... 200 1 60/60 200
Phase 2 Consent ............................. 50 1 15/60 13
Phase 2 HIV Symptom and Care 50 9 5/60 38
survey.
Phase 2 Behavioral Survey ............. 50 1 30/60 25
Total ........................................... .......................................................... ........................ ........................ ........................ 2,110
Jeffrey M. Zirger,
sradovich on DSK3GMQ082PROD with NOTICES
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–17980 Filed 8–20–18; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014 19:37 Aug 20, 2018 Jkt 244001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\21AUN1.SGM 21AUN1](https://thefederalregister.org/doc/83_FR_42463/page/2.svg)
![Federal Register / Vol. 83, No. 162 / Tuesday, August 21, 2018 / Notices 42303
DEPARTMENT OF HEALTH AND SUPPLEMENTARY INFORMATION: reasonable alternatives to the proposed
HUMAN SERVICES Background: CDC is dedicated to action before making a decision. In
protecting health and promoting quality compliance with NEPA, CDC published
Centers for Disease Control and of life through the prevention and a Draft EIS for the proposed site
Prevention control of disease, injury, and disability. acquisition and campus consolidation
[Docket No. CDC–2017–0059]
NIOSH, one of CDC’s Centers, Institutes, on February 9, 2018 and a Final EIS on
and Offices, was established by the July 20, 2018. The Draft EIS was
Notice of Availability of Record of Occupational Safety and Health Act of available for public review and
Decision for Site Acquisition and 1970. NIOSH plans, directs, and comment for 45 days. All comments
Campus Consolidation for the Centers coordinates a national program to received were considered when
for Disease Control and Prevention/ develop and establish recommended preparing the Final EIS. The Draft and
National Institute for Occupational occupational safety and health Final EIS analyzed two alternatives: the
Safety and Health (CDC/NIOSH), standards; conduct research and Proposed Action Alternative
Cincinnati, Ohio training; provide technical assistance; (acquisition of the Site and construction
and perform related activities to assure of a new, consolidated CDC/NIOSH
AGENCY: Centers for Disease Control and safe and healthful working conditions campus) and the No Action Alternative
Prevention (CDC), Department of Health for every working person in the United (continued use of the existing campuses
and Human Services (HHS). States. for the foreseeable future). The Final EIS
ACTION: Notice. Currently, three NIOSH research identified the Proposed Action
facilities—the Robert A. Taft Campus, Alternative as CDC’s Preferred
SUMMARY: The Centers for Disease Taft North Campus, and the Alice Alternative.
Control and Prevention (CDC) within Hamilton Laboratory Campus—are After carefully considering the Final
the Department of Health and Human located in Cincinnati, Ohio. These EIS and all comments received, CDC has
Services (HHS), in cooperation with the facilities no longer meet the research made the decision to implement the
U.S. General Services Administration needs required to support occupational Proposed Action Alternative. CDC’s
(GSA), announces the availability of the safety and health in the modern rationale for this decision is detailed in
Record of Decision (ROD) for the workplace. The facilities’ deficiencies the ROD. The ROD incorporates all the
acquisition of a site in Cincinnati, Ohio, adversely affect NIOSH’s ability to mitigation and minimization measures
and development of this site into a new, conduct occupational safety and health described in the Final EIS.
consolidated CDC/National Institute for research in Cincinnati. It is not possible
Occupational Safety and Health Dated: August 13, 2018.
to renovate the facilities located on the
(NIOSH) campus (Proposed Action). Sandra Cashman,
three campuses to meet current
The site to be acquired is bounded by standards and requirements. Executive Secretary, Centers for Disease
Martin Luther King Drive East to the Control and Prevention.
Additionally, the current distribution of
south, Harvey Avenue to the west, NIOSH activities across separate [FR Doc. 2018–17707 Filed 8–20–18; 8:45 am]
Ridgeway Avenue to the north, and campuses in Cincinnati results in BILLING CODE 4163–18–P
Reading Road to the east. inefficiencies in scientific collaboration
CDC published a Final Environmental
and the duplication of operational
Impact Statement (EIS) for this action on DEPARTMENT OF HEALTH AND
support activities. To address these
July 20, 2018 pursuant to the HUMAN SERVICES
issues, CDC proposed to relocate and
requirements of the National
consolidate its Cincinnati-based Centers for Disease Control and
Environmental Policy Act (NEPA) of
functions and personnel (approximately Prevention
1969 as implemented by the Council on
550 employees) currently housed at the
Environmental Quality (CEQ) [Docket Number CDC–2018–0059; NIOSH–
three existing campuses to a new,
Regulations (40 CFR parts 1500–1508). 315]
consolidated campus in Cincinnati.
CDC carefully considered the findings of Potential locations for the new
the Final EIS when making its decision. Request for Information About
campus were identified through a
ADDRESSES: The ROD is available for Inorganic Lead (CAS No. 7439–92–1)
comprehensive site selection process
viewing on the Federal eRulemaking conducted by GSA on behalf of CDC. In AGENCY: National Institute for
Portal: http://www.regulations.gov June 2016, GSA issued a Request for Occupational Safety and Health
(reference Docket No. CDC–2017–0059). Expressions of Interest (REOI) seeking (NIOSH) of the Centers for Disease
A limited number of printed copies are potential sites capable of Control and Prevention (CDC),
available upon request to cdc- accommodating the proposed new Department of Health and Human
cincinnati-eis@cdc.gov or Harry Marsh, campus. In response to the REOI, GSA Services (HHS).
Architect, Office of Safety, Security and received seven expressions of interest. ACTION: Request for information.
Asset Management (OSSAM), Centers Following an assessment of each site,
for Disease Control and Prevention, GSA found that only one site qualified SUMMARY: The National Institute for
1600 Clifton Road NE, MS–K80, Atlanta, for further consideration (the Site). The Occupational Safety and Health
Georgia 30329–4027. All U.S. Mail Site encompasses all land between (NIOSH) of the Centers for Disease
communications must include the Martin Luther King Drive East to the Control and Prevention (CDC) intends to
agency name and Docket Number. south, Harvey Avenue to the west, evaluate the scientific data on inorganic
FOR FURTHER INFORMATION CONTACT: lead, to develop updated
sradovich on DSK3GMQ082PROD with NOTICES
Ridgeway Avenue to the north, and
Harry Marsh, Architect, Office of Safety, Reading Road to the east in Cincinnati, recommendations on the potential
Security and Asset Management Ohio. health risks, medical surveillance,
(OSSAM), Centers for Disease Control Under NEPA, as implemented by CEQ recommended measures for safe
and Prevention, 1600 Clifton Road NE, Regulations (40 CFR parts 1500–1508), handling, and to establish an updated
MS–K80, Atlanta, Georgia 30329–4027, Federal agencies are required to Recommended Exposure Limit (REL).
phone: (770) 488–8170, or email: cdc- evaluate the environmental effects of DATES: Electronic or written comments
cincinnati-eis@cdc.gov. their proposed actions and a range of must be received by October 22, 2018.
VerDate Sep<11>2014 19:37 Aug 20, 2018 Jkt 244001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\21AUN1.SGM 21AUN1](https://thefederalregister.org/doc/83_FR_42463/page/3.svg)
Document Created: 2018-08-21 00:07:25
Document Modified: 2018-08-21 00:07:25
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice with comment period. | |
| Dates | CDC must receive written comments on or before October 22, 2018. | |
| FR Citation | 83 FR 42301 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR